Esperion Therapeutics
ESPR
#6808
Rank
S$0.76 B
Marketcap
S$3.21
Share price
-7.56%
Change (1 day)
56.76%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -S$37.01 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.30 Billion. In 2024 the company made an earning of S$9.62 Million, an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.01 Million-484.62%
2024 S$9.62 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.26 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$95.64 Million51.43%
2015 -S$63.16 Million36.45%
2014 -S$46.29 Million43.55%
2013 -S$32.25 Million145.26%
2012 -S$13.15 Million
2002 -S$37.48 Million-7.81%
2001 -S$40.66 Million15.03%
2000 -S$35.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.19 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.70 B-19,161.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.67 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$87.92 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.38 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA